172 related articles for article (PubMed ID: 27822612)
1. Perceived Life Expectancy Is Associated with Colorectal Cancer Screening in England.
Kobayashi LC; von Wagner C; Wardle J
Ann Behav Med; 2017 Jun; 51(3):327-336. PubMed ID: 27822612
[TBL] [Abstract][Full Text] [Related]
2. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
Hategekimana C; Karamouzian M
Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
[TBL] [Abstract][Full Text] [Related]
3. Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing.
Kobayashi LC; Wardle J; von Wagner C
Prev Med; 2014 Apr; 61(100):100-5. PubMed ID: 24287122
[TBL] [Abstract][Full Text] [Related]
4. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
5. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers.
Smith SG; McGregor LM; Raine R; Wardle J; von Wagner C; Robb KA
Psychooncology; 2016 Oct; 25(10):1168-1174. PubMed ID: 27309861
[TBL] [Abstract][Full Text] [Related]
6. Cognitive ability and personality as predictors of participation in a national colorectal cancer screening programme: the English Longitudinal Study of Ageing.
Gale CR; Deary IJ; Wardle J; Zaninotto P; Batty GD
J Epidemiol Community Health; 2015 Jun; 69(6):530-5. PubMed ID: 25648994
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
8. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
[TBL] [Abstract][Full Text] [Related]
10. Perceived life expectancy and colorectal cancer screening intentions and behaviour: A population-based UK study.
Dodd RH; Kobayashi LC; von Wagner C
Prev Med Rep; 2019 Dec; 16():101002. PubMed ID: 31709135
[TBL] [Abstract][Full Text] [Related]
11. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
12. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
[TBL] [Abstract][Full Text] [Related]
13. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
14. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Educational Intervention Based on Health Belief Model and Social Support on the Rate of Participation of Individuals in Performing Fecal Occult Blood Test for Colorectal Cancer Screening.
Gholampour Y; Jaderipour A; Khani Jeihooni A; Kashfi SM; Afzali Harsini P
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2777-2787. PubMed ID: 30360606
[TBL] [Abstract][Full Text] [Related]
16. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
[TBL] [Abstract][Full Text] [Related]
17. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
Lipkus IM; Green LG; Marcus A
J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
[TBL] [Abstract][Full Text] [Related]
18. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal adherence with fecal occult blood test screening in community practice.
Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
[TBL] [Abstract][Full Text] [Related]
20. Decomposing socio-economic inequality in colorectal cancer screening uptake in England.
Solmi F; Von Wagner C; Kobayashi LC; Raine R; Wardle J; Morris S
Soc Sci Med; 2015 Jun; 134():76-86. PubMed ID: 25917138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
